An article in MSN Health this week reports a drug commonly used to treat patients with Alzheimer’s disease does not appear to be effective for people older than 40 years who have Down syndrome and Alzheimer’s, according to a new study.
“Although previous animal studies of the Alzheimer’s drug, memantine, showed promising results in mice with Down syndrome, this new study of people with Down syndrome aged 40 and older revealed the opposite, the researchers reported in the Jan. 9 online edition of The Lancet.
Memantine was given to 88 people with Down syndrome for one year, while another 85 patients received a placebo (the “control” group). Some of the participants had Alzheimer’s and some didn’t.”
Read more about what they found as well as the implications: